Global Patent Index - EP 1137779 A2

EP 1137779 A2 20011004 - IDENTIFICATION OF SENV GENOTYPES

Title (en)

IDENTIFICATION OF SENV GENOTYPES

Title (de)

FESTSTELLUNG VON SENV GENOTYPEN

Title (fr)

IDENTIFICATION DE GENOTYPES SENV

Publication

EP 1137779 A2 20011004 (EN)

Application

EP 99971855 A 19991109

Priority

  • EP 99971855 A 19991109
  • EP 9908566 W 19991109
  • EP 99830298 A 19990514
  • EP 99113932 A 19990716
  • IT MI982437 A 19981110
  • IT MI990923 A 19990430

Abstract (en)

[origin: WO0028039A2] The present invention relates to a nucleic acid molecule representing the genome of a virus/viral agent, said nucleic acid molecule having at least one of the following features: (a) it contains at least one open reading frame (ORF) which encodes a polypeptide having an amino acid sequence disclosed herein; (b) it comprises a DNA sequence as described herein; (c) it hybridizes preferably under stringent conditions to the complementary strand of the nucleic acid molecule described herein, but not to the complementary strand of the genome of TT virus; (d) it is degenerate with respect to the hybridizing nucleic acid molecule; (e) it is at least 60 % identical with the nucleic acid molecule representing the genome of the virus/viral agent of the invention; and (f) parts of it can be amplified under suitable conditions by PCR employing primers as defined herein. The invention further relates to vectors comprising said nucleic acid molecule, methods of producing (poly)peptide(s) encoded by said nucleic acid molecule, to viruses/viral agents carrying a genome represented by said nucleic acid molecule and antibodies to said (poly)peptide(s) and/or said viruses/viral agents. Additionally, the invention relates to compositions, preferably pharmaceutical compositions, vaccines, diagnostics and diagnostic kits comprising or employing the compounds of the invention.

IPC 1-7

C12N 15/34; C07K 14/01; C12P 21/00; C12N 7/00; C12N 7/02; C07K 16/08; A61K 39/12; A61K 39/42; C07K 19/00; G01N 33/569; C12Q 1/68; C12Q 1/70; A61P 1/00; A61P 35/00

IPC 8 full level

G01N 33/50 (2006.01); A61K 35/76 (2006.01); A61K 38/00 (2006.01); A61K 39/12 (2006.01); A61K 39/395 (2006.01); A61K 39/42 (2006.01); A61K 48/00 (2006.01); A61P 1/00 (2006.01); A61P 1/16 (2006.01); A61P 29/00 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); C07K 14/005 (2006.01); C07K 14/01 (2006.01); C07K 16/08 (2006.01); C07K 19/00 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 7/00 (2006.01); C12N 7/02 (2006.01); C12N 15/02 (2006.01); C12N 15/09 (2006.01); C12N 15/34 (2006.01); C12P 21/00 (2006.01); C12P 21/02 (2006.01); C12P 21/08 (2006.01); C12Q 1/68 (2006.01); C12Q 1/70 (2006.01); G01N 33/53 (2006.01); G01N 33/536 (2006.01); G01N 33/566 (2006.01); G01N 33/569 (2006.01); A61K 35/13 (2015.01); A61K 39/00 (2006.01)

CPC (source: EP)

A61P 1/00 (2018.01); A61P 1/16 (2018.01); A61P 29/00 (2018.01); A61P 31/12 (2018.01); A61P 35/00 (2018.01); C07K 14/005 (2013.01); C12Q 1/706 (2013.01); A61K 35/13 (2013.01); A61K 38/00 (2013.01); A61K 39/00 (2013.01); A61K 2039/505 (2013.01); A61K 2039/525 (2013.01); A61K 2039/53 (2013.01); C07K 2319/00 (2013.01); C12N 2750/00021 (2013.01); C12N 2750/00022 (2013.01)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 0028039 A2 20000518; WO 0028039 A3 20001005; AR 021143 A1 20020612; AU 1381600 A 20000529; EP 1137779 A2 20011004; JP 2002529092 A 20020910; NO 20012276 D0 20010509; NO 20012276 L 20010709; PE 20001331 A1 20001219; TN SN99210 A1 20051110

DOCDB simple family (application)

EP 9908566 W 19991109; AR P990105694 A 19991110; AU 1381600 A 19991109; EP 99971855 A 19991109; JP 2000581206 A 19991109; NO 20012276 A 20010509; PE 00113799 A 19991110; TN SN99210 A 19991108